To date, 61 different miRNAs targeting AD-related genes have been reported, eventually contributing to APP cleavage, Aβ metabolism, microtubule-associated protein tau (MAPT) regulation, and synaptic plasticity [120]. Here, MAPT is linked to Alzheimer disease.